SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS…
Dupixent (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Five times more adults on Dupixent achieved sustained disease remission at 36…
KFSHRCs Dr. Jackie Ying Named in Forbes 50 Over 50 Global 2025 List
RIYADH, Saudi Arabia, March 04, 2025 (GLOBE NEWSWIRE) -- Dr. Jackie Ying,…
Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
– First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) – –…
Longeveron Announces Full-Year 2024 Financial Results and Provides Business Update
Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left…
Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps
TEZSPIRE significantly reduced nasal congestion, polyp size and nearly eliminated the need…
Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing
SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing…
Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand
First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction…
AMITY UNIVERSITY GURUGRAM, HARYANA, HOSTS ITS 11TH CONVOCATION CEREMONY AT MANEKSHAW CENTRE, NEW DELHI
Recognizes Dr. Arvinder Singh Soin, Group Chairman & Chief Liver Transplant Surgeon,…
Creative Medical Technology Reports Positive One-Year Results for AlloStem Type 2 Diabetes Program
Significant Efficacy and No Serious Adverse Effects Observed with CELZ-201 February 11,…